Clarification
Natco Pharma Ltd has submitted to BSE a copy of the clarification in response to speculation about Generic Copaxone.03-04-2014
03-04-2014
NATCO comments on Copaxone patent
Natco Pharma Ltd has informed BSE regarding a Press Release dated April 01, 2014 titled "NATCO comments on Copaxone patent".01-04-2014
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Natco Group Employees Welfare Trust has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201127-03-2014
NATCO Pharma announces USFDA tentative approval of Oseltamivir Phosphate Capsules
Natco Pharma Ltd has informed BSE regarding a Press Release dated March 18, 2014, titled "NATCO Pharma announces USFDA tentative approval of Oseltamivir Phosphate Capsules".18-03-2014
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Natco Group Employees Welfare Trust has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118-03-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Natco Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199212-03-2014
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Neelima Nannapaneni Trust has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201112-03-2014
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Natco Group Employees Welfare Trust has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201104-03-2014
NATCO Comments on Decision by New Delhi High Court Against Teva
Natco Pharma Ltd has informed BSE regarding a Press Release dated March 01, 2014, titled "NATCO Comments on Decision by New Delhi High Court Against Teva".03-03-2014
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Natco Group Employees Welfare Trust has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201125-02-2014